Johnson & Johnson is again calling on Tucson for it's COVID-19 vaccine trial.
This time, the drug maker is checking on a two-shot version of it's vaccine.
Johnson & Johnson is again calling on Tucson for it's COVID-19 vaccine trial.
This time, the drug maker is checking on a two-shot version of it's vaccine.